Corporate Overview
Etico Lifesciences Private Limited is a premier Contract Development & Manufacturing Organization (CDMO) incorporated in 2016. We specialize in the development of niche generic and specialty pharmaceutical products with a strong focus on clinical excellence.
Our operation is anchored by a multidisciplined team of 90+ professionals possessing an excellent track record in complex pharmaceutical R&D. We hold specialized permits from regulatory authorities to work with Narcotics, Psychotropic, and Controlled substances for research purposes.
Partner With Us
Evolution & Milestones
2016
Incorporation of Etico Lifesciences.
2017
Signed our First Licensing Agreement.
2019
Launched Stand-alone Advanced Analytical Services.
2020
Established full OSD (Oral Solid Dosage) Capability.
2022
Achievement of our first ANDA approval.
2023
First Peptide Out-licensing with Profit Share milestone.
2024
Clinical success with successful Pre-IND for 2 products.
2025
Targeted successful Pre-IND for our primary specialty product.
Global Strategic Partnerships
Serving esteemed clients across the most highly regulated global markets:
United States
European Union
United Kingdom
Canada
Australia
GCC Region
Our Certifications
ISO
Certified
DSIR
Recognized
GLP
Compliant
DCA
Accredited
Compliance with international ICH and regulatory safety standards.